$5.49 -0.18 (-3.17%)
2/10/2012 3:59 PM

Maxygen, Inc. (NASDAQ:MAXY)

CAPS Rating: 4 out of 5

A biotechnology company committed to the discovery and development of improved next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions.

Featured Broker Partners


Advertisement